Discussing the latest treatments in B-cell lymphomas at this year’s virtual ASCO 2021 meeting Professor John Seymour, Director of the integrated Haematology Department of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital in Melbourne, weighed up three recently FDA approved drug classes in relapsed follicular lymphoma, marginal zone lymphoma and Waldenstrom’s macroglobulinemia. Among ...
ASCO 21: Professor John Seymour on the latest in B-cell lymphoma treatments
By Sunalie Silva
10 Jun 2021